Skip to main content
. 2020 Dec 21;28(1):87–99. doi: 10.1080/10717544.2020.1858999

Table 2.

Characterization of the prepared plain/medicated sponges.

Parameter
Muco-adhesion time (minutes)
Ex-vivo muco-adhesion force (N)
Formula Surface pH Porosity (%) Swelling index In-vivo Ex-vivo
Plain sponge            
 C0.5 6.36 ± 0.026 21 ± 1.2 0.48 ± 0.01 60 ± 0.547 **NA **NA
 C1 6.35 ± 0.037 23.5 ± 0.9 3.92 ± 0.06 120 ± 1.1136 **NA **NA
 C2 6.33 ± 0.01 26 ± 1.5 5.23 ± 0.09 116 ± 1.11 **NA **NA
 M1 6.79 ± 0.03 35 ± 2.5 3.788 ± 0.1 15 ± 2.64 **NA **NA
*Medicated sponge            
 mC0.5 6.29 ± 0.091*** 22 ± 0.88*** 0.55 ± 0.04*** 59 ± 1.62 *** 90 ± 0.53 0.014 ± 0.0115
 mC1 6.26 ± 0.066*** 23.8 ± 1.1*** 3.68 ± 0.03*** 123 ± 0.113*** 136 ± 0.197 0.032 ± 0.0057
 mC2 6.30 ± 0.042*** 25.7 ± 1.8*** 5.70 ± 0.11*** 115 ± 0.813*** 155 ± 1.537 0.09 ± 0.002
 mM1 6.68 ± 0.12*** 36.2 ± 1.7*** 3.529 ± 0.8*** 19 ± 0.48*** 30 ± 0.1 0.06 ± 0.002

*Medicated sponge contains 10 mg% miconazole nitrate and 6 mg% tenoxiam. **NA means Not Applied experiment. *** Symbol means results insignificantly different (p > .05) from plain sponges.